Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Radiolabeled Monoclonal Antibody Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory or Recurrent Ovarian Epithelial Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE3
Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Capecitabine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1